Pediatric Pharmacokinetics Human Development and Drug Disposition

被引:35
|
作者
Funk, Ryan S. [1 ]
Brown, Jacob T. [1 ]
Abdel-Rahman, Susan M. [1 ,2 ]
机构
[1] Childrens Mercy Hosp & Clin, Div Clin Pharmacol & Med Toxicol, Kansas City, MO 64108 USA
[2] Univ Missouri, Dept Pediat, Sch Med, Kansas City, MO 64108 USA
关键词
Pediatric; Pharmacokinetic; Development; Absorption; Distribution; Metabolism; Excretion; Transport; SINGLE-DOSE PHARMACOKINETICS; PLASMA-PROTEIN BINDING; AGE-RELATED-CHANGES; TISSUE DISTRIBUTION; HUMAN LIVER; POPULATION PHARMACOKINETICS; INTRAVENOUS OMEPRAZOLE; HEALTHY-VOLUNTEERS; PRETERM INFANTS; SMALL-INTESTINE;
D O I
10.1016/j.pcl.2012.07.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Human development is described by the various anatomic and physiologic changes that occur as the single-celled zygote matures into an adult human being. Concomitant with bodily maturation are changes in the complex interactions between pharmacologic agents and the biologic matrix that is the human body. Profound changes in the manner by which drugs traverse the body during development can have significant implications in drug efficacy and toxicity. Although not a replacement for well-conducted, pediatric, pharmacokinetic studies, an understanding of developmental biology and the mechanisms for drug disposition invariably assists the pediatric clinician with the judicious use of medications in children.
引用
收藏
页码:1001 / +
页数:17
相关论文
共 50 条
  • [41] Drug disposition in cholestasis: An important concern
    Shang, Tianze
    Zhang, Chengliang
    Liu, Dong
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (04):
  • [42] Improving the prediction of drug disposition in the brain
    Lanevskij, Kiril
    Japertas, Pranas
    Didziapetris, Remigijus
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (04) : 473 - 486
  • [43] Natural health products and drug disposition
    Foster, BC
    Arnason, JT
    Briggs, CJ
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 : 203 - 226
  • [44] Ocular Pharmacokinetics of a Novel Tetrahydroquinoline Analog in Rabbit: Absorption, Disposition, and Non-compartmental Analysis
    Pamulapati, Chandrasena R.
    Schoenwald, Ronald D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (12) : 5315 - 5323
  • [45] Quantitative Prediction of Human Pharmacokinetics for mAbs Exhibiting Target-Mediated Disposition
    Singh, Aman P.
    Krzyzanski, Wojciech
    Martin, Steven W.
    Weber, Gregory
    Betts, Alison
    Ahmad, Alaa
    Abraham, Anson
    Zutshi, Anup
    Lin, John
    Singh, Pratap
    AAPS JOURNAL, 2015, 17 (02): : 389 - 399
  • [46] The In Silico Child: Using Simulation to Guide Pediatric Drug Development and Manage Pediatric Pharmacotherapy
    Laeer, Stephanie
    Barrett, Jeffrey S.
    Meibohm, Bernd
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (08) : 889 - 904
  • [47] Pharmacokinetics in drug discovery
    Ruiz-Garcia, Ana
    Bermejo, Marival
    Moss, Aaron
    Casabo, Vicente G.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (02) : 654 - 690
  • [48] Development of a Hybrid Physiologically Based Pharmacokinetic Model with Drug-Specific Scaling Factors in Rat to Improve Prediction of Human Pharmacokinetics
    Sayama, Hiroyuki
    Komura, Hiroshi
    Kogayu, Motohiro
    Iwaki, Masahiro
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (11) : 4193 - 4204
  • [49] Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse
    Shebley, Mohamad
    Menon, Rajeev M.
    Gibbs, John P.
    Dave, Nimita
    Kim, Su Y.
    Marroum, Patrick J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (05) : 625 - 637
  • [50] The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition
    Bensalem, Amina
    Cartron, Guillaume
    Specks, Ulrich
    Mulleman, Denis
    Gyan, Emmanuel
    Cornec, Divi
    Desvignes, Celine
    Casasnovas, Olivier
    Lamy, Thierry
    Lepretre, Stephane
    Paintaud, Gilles
    Ternant, David
    CLINICAL PHARMACOKINETICS, 2022, 61 (03) : 423 - 437